Clinical Trials Logo

Filter by:
NCT ID: NCT05106959 Completed - Shame Clinical Trials

Piloting a Motivational Interviewing Shame-Resilience Training

MIST
Start date: June 26, 2020
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the shame resilience theory in a pilot context to assess its feasibility in a potential full scale clinical trial. Shame resilience was developed through qualitative methods but currently has little quantitative backing. Continued research is needed to assess shame-resilience as a potential intervention for shame which little is known to combat prevalent negative health outcomes associated with shame.

NCT ID: NCT05106816 Completed - Parkinson Disease Clinical Trials

The Effects of Vibrotactile Stimulation in Patients With Movement Disorders

Start date: October 7, 2021
Phase: N/A
Study type: Interventional

Vibration applied to the skin has been anecdotally reported to potentially improve motor control in patients with movement disorders including Parkinson's disease, however few devices have been studied formally. In this study, the investigators will test the effect of skin surface vibration applied non-invasively to patients with movement disorders to determine if there are any beneficial effects on common tasks of motor control and/or abnormal motor symptoms in patients with Parkinson's disease (PD), essential tremor (ET), and dystonia.

NCT ID: NCT05106647 Completed - Stress Clinical Trials

Reducing Work-related Screen Time in Health Care Workers During Leisure Time

REDUCE-SCREEN
Start date: November 9, 2021
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect that uninstalling work email applications from mobile devices during leisure time has on health care worker stress levels.

NCT ID: NCT05106595 Completed - Stroke, Acute Clinical Trials

Bimanual Arm Training in Acute Stroke

Start date: May 10, 2022
Phase:
Study type: Observational [Patient Registry]

Recent studies have shown that completing bilateral simultaneous movements during upper extremity practice may result in facilitation of coactivation and interhemispheric activation of both the ipsilesional and contralesional brain areas, with one limb entraining the other and enabling the limbs to function as a unit. Other research has proposed that the use of virtual-reality (VR) activities during treatment sessions can improve upper extremity function following stroke as it is motivating, challenging, offers external feedback that may facilitate motor learning, and allows for the "high-intensity, repetitious practice necessary to drive recovery". Coupling bilateral simultaneous upper extremity movement and virtual-reality activities is the Bimanual Arm Trainer (BAT), a non-powered mechanical device by which the non-paretic upper extremity moves the paretic arm. The purpose of this study is to determine the effectiveness of the Bimanual Arm Trainer (BAT) compared to traditional occupational therapy treatment sessions as these relate to upper extremity functional return following stroke, as measured by scores on the Action Research Arm Test (ARAT) and Upper Extremity Fugl-Meyer Assessment (UE-FMA) measures. The investigators plan to use retrospective data for a pre-implementation group, comparing this data to prospectively collected post-implementation data. ARAT scores are routinely collected and will be used for comparison between groups. UE-FMA measures are commonly used in this area of research, and will be taken to provide additional context for the post-implementation group.

NCT ID: NCT05106439 Completed - Telemedicine Clinical Trials

Intern Health Study: 2020 Cohort Micro-Randomized Trial

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The aim of this study is to evaluate the efficacy of gamified competition (delivered through a smartphone) for improving the physical activity and sleep of medical interns.

NCT ID: NCT05106400 Completed - Healthy Clinical Trials

Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing Patches

Start date: July 1, 2021
Phase: Phase 1
Study type: Interventional

The study is designed to evaluate and compare the clinical adhesion performance of the ZTlido (Lidocaine Topical System) 1.8% of Scilex Pharmaceuticals Inc. (Reference) versus Salonpas (Lidocaine Patch 4%), Aspercreme (Lidocaine Patch 4%) and IcyHot (Lidocaine 4% + Menthol 1% Patch), on the Mid to upper back while being worn for 12 hours in healthy adult human subjects.

NCT ID: NCT05106309 Completed - Schizophrenia Clinical Trials

Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy Participants

Start date: December 29, 2021
Phase: Phase 1
Study type: Interventional

A 2-part, crossover design, open-label treatment trial with 4 periods, 4 sequences (Part A) to evaluate MR formulations of CVL-231 and a 2 periods, 2 sequences (Part B) to understand effect of food on CVL-231 exposures from an MR formulation.

NCT ID: NCT05106257 Completed - Copd Clinical Trials

Optimizing Self-management COPD Treatment Through the American Lung Association Helpline

Start date: November 5, 2021
Phase: N/A
Study type: Interventional

Although self-management treatment improves quality of life among individuals with COPD, there is limited understanding of which elements of treatment are most effective. The proposed research will test the feasibility of using an engineering-inspired study design to identify effective COPD self-management treatment components. The long-term goal of this line of research is to optimize the effectiveness of COPD self-management treatment, and improve quality of life for individuals with COPD.

NCT ID: NCT05106153 Completed - Abuse Potential Clinical Trials

A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and Zolpidem

Start date: December 17, 2021
Phase: Phase 1
Study type: Interventional

The purpose of this study is to evaluate the abuse potential of seltorexant compared to placebo and two active comparators (zolpidem and suvorexant) in non-dependent, recreational sedative users.

NCT ID: NCT05106101 Completed - Clinical trials for Diverticulosis, Colonic

L-glutamine Treatment in Patients With Diverticulosis

Start date: July 19, 2019
Phase: Phase 1
Study type: Interventional

The purpose of the study is evaluate the safety and efficacy of L-glutamine as a treatment for patients with diverticulosis.